Correspondingly, eEF2K has tumor-suppressive functions in CRC, as depletion of eEF2K enhances cell survival in CRC and low expression levels of eEF2K in CRC patient tissue samples correlate with poor clinical outcome [101,102]. Here, EEF2K is linked to colorectal carcinoma.